Regulatory Resources
Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools
MDCG 2025-9: Guidance on Breakthrough Devices (BtX) under Regulations 2017/745 & 2017/746
MDCG 2019-9: Summary of safety and clinical performance
MDCG 2020-5: Guidance on clinical evaluation – Equivalence
MDCG 2020-6: Guidance on sufficient clinical evidence for legacy devices
MDCG 2020-7: Guidance on PMCF plan template
MDCG 2020-8: Guidance on PMCF evaluation report template
MDCG 2020-10/1: Guidance on safety reporting in clinical investigations
MDCG 2020-13: Clinical evaluation assessment report template
MDCG 2021-6: Q&A regarding clinical investigation under Regulation 2017/745
MDCG 2021-8: Clinical investigation application/notification documents
Loading more resources…